Sarah French

Dr. Sarah French is an Assistant Professor of Medicine at the University of California, San Francisco (UCSF) School of Medicine, specializing in rheumatology. She serves as co-director of the UCSF Scleroderma Clinic and focuses on systemic rheumatic diseases like lupus and scleroderma. Her research examines scleroderma's cardiovascular and pulmonary impacts, as well as osteoporosis care improvement. She earned her MD from UCSF, completed residency at Stanford University, and returned to UCSF for a rheumatology fellowship, serving as chief fellow.

Education:

• University of California, San Francisco: M.D., 2014
• Stanford University School of Medicine: Internal Medicine Residency, 2017
• UCSF: Rheumatology Fellowship, 2020

Research Interests: Dr. French investigates rheumatology-related complications, including inflammatory pathways in lupus and the effects of scleroderma on vital organs. Her work integrates clinical care with translational research to improve patient outcomes in chronic autoimmune diseases.

Publications: Her research spans areas like multisystem inflammatory syndrome post-SARS-CoV-2, osteoporosis quality metrics, and genetic studies of fungal pathogens. Recent work highlights the role of telomere length in interstitial lung disease progression and non-invasive cardiac indices in pulmonary arterial hypertension.

Grants/Awards: No awards explicitly listed, but her academic senate membership and ORNG applications suggest active research funding. She collaborates with institutions like Stanford and COMET Consortium.

Labs/Teams: Co-directs the UCSF Scleroderma Clinic, contributing to clinical and research efforts in systemic sclerosis management.